Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cogent Biosciences, Inc. | 1,138,274 | reported | 03 Apr 2018 | tx 4+1,138,274−1,787,241 |
| Bicara Therapeutics Inc. | 1,013,853 | reported | 16 Sept 2024 | tx 6+1,013,853−1,013,853 |
| Surface Oncology, Inc. | 886,716 | reported | 23 Apr 2018 | tx 2+886,716−1,950,777 |
| IRONWOOD PHARMACEUTICALS INC | 837,736 | reported | 28 Mar 2013 | tx 18−869,796 |
| Structure Therapeutics Inc. | 494,035 | reported | 07 Feb 2023 | tx 18+6,473,761−6,473,761 |
| Xilio Therapeutics, Inc. | 218,705 | reported | 26 Oct 2021 | tx 2+218,705−2,077,698 |
| Denali Therapeutics Inc. | 0 | reported | 12 Dec 2017 | tx 42+3,273,807−3,273,807 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Sept 2024 | CONVERSION | Bicara Therapeutics Inc. | 352,876 | — | |
| 16 Sept 2024 | CONVERSION | Bicara Therapeutics Inc. | 606,885 | — | |
| 16 Sept 2024 | CONVERSION | Bicara Therapeutics Inc. | 54,092 | — | |
| 16 Sept 2024 | CONVERSION | Bicara Therapeutics Inc. | 606,885 | — | deriv |
| 16 Sept 2024 | CONVERSION | Bicara Therapeutics Inc. | 54,092 | — | deriv |
| 16 Sept 2024 | CONVERSION | Bicara Therapeutics Inc. | 352,876 | — | deriv |
| 07 Feb 2023 | CONVERSION | Structure Therapeutics Inc. | 4,013,678 | — | |
| 07 Feb 2023 | CONVERSION | Structure Therapeutics Inc. | 620,499 | — | |
| 07 Feb 2023 | CONVERSION | Structure Therapeutics Inc. | 179,242 | — | |
| 07 Feb 2023 | CONVERSION | Structure Therapeutics Inc. | 71,636 | — | |
| 07 Feb 2023 | CONVERSION | Structure Therapeutics Inc. | 10,154 | — | |
| 07 Feb 2023 | CONVERSION | Structure Therapeutics Inc. | 7,411 | — | |
| 07 Feb 2023 | CONVERSION | Structure Therapeutics Inc. | 452,867 | — | |
| 07 Feb 2023 | CONVERSION | Structure Therapeutics Inc. | 624,239 | — | |
| 07 Feb 2023 | CONVERSION | Structure Therapeutics Inc. | 494,035 | — | |
| 07 Feb 2023 | CONVERSION | Structure Therapeutics Inc. | 624,239 | — | deriv |
| 07 Feb 2023 | CONVERSION | Structure Therapeutics Inc. | 494,035 | — | deriv |
| 07 Feb 2023 | CONVERSION | Structure Therapeutics Inc. | 7,411 | — | deriv |
| 07 Feb 2023 | CONVERSION | Structure Therapeutics Inc. | 10,154 | — | deriv |
| 07 Feb 2023 | CONVERSION | Structure Therapeutics Inc. | 71,636 | — | deriv |
| 07 Feb 2023 | CONVERSION | Structure Therapeutics Inc. | 179,242 | — | deriv |
| 07 Feb 2023 | CONVERSION | Structure Therapeutics Inc. | 452,867 | — | deriv |
| 07 Feb 2023 | CONVERSION | Structure Therapeutics Inc. | 620,499 | — | deriv |
| 07 Feb 2023 | CONVERSION | Structure Therapeutics Inc. | 4,013,678 | — | deriv |
| 26 Oct 2021 | CONVERSION | Xilio Therapeutics, Inc. | 218,705 | — |